NASDAQ:AAAPAdvanced Accelerator Application Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Advanced Accelerator Application SA Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $81.63 0.00 (0.00 %) (As of 02/20/2018) Add Compare Share Today's Range$81.63Now: $81.63▼$81.6350-Day Range N/A52-Week Range$35.11Now: $81.63▼$82.74VolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileEarningsInstitutional OwnershipHeadlinesSocial Media Advanced Accelerator Applications S.A. is a radiopharmaceutical company. The Company develops, produces and commercializes molecular nuclear medicine (MNM), diagnostic and therapeutic products. MNM uses trace amounts of radioactive compounds to create functional images of organs and lesions and to treat diseases, such as cancer. The Company has a portfolio of nine diagnostic positron emission tomography (PET) and single-photon emission computed tomography (SPECT) products. PET and SPECT are imaging techniques in molecular nuclear diagnostics (MND) with applications in clinical oncology, cardiology, neurology and inflammatory/infectious diseases. Its commercial products include Gluscan/Gluscan 500/Barnascan, FluoroChol, MIBITEC/Adamibi, DOPAVIEW, Leukokit, Neurolite, SomaKit and NETSPOT. Additional MND product candidates include Annexin V-128, a SPECT product candidate for the imaging of apoptotic and necrotic lesions with potential applications in a range of indications.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Advanced Accelerator Application. Previous Next 2.6 Community Rank Outperform VotesAdvanced Accelerator Application has received 271 “outperform” votes. (Add your “outperform” vote.)Underperform VotesAdvanced Accelerator Application has received 252 “underperform” votes. (Add your “underperform” vote.)Community SentimentAdvanced Accelerator Application has received 51.82% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Advanced Accelerator Application and other stocks. Vote “Outperform” if you believe AAAP will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AAAP will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldAdvanced Accelerator Application does not currently pay a dividend.Dividend GrowthAdvanced Accelerator Application does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Advanced Accelerator Application insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.52 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AAAP Previous Symbol CUSIPN/A CIKN/A Webwww.adacap.com Phone33-04-50-99-30-70Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive AAAP News and Ratings via Email Sign-up to receive the latest news and ratings for AAAP and its competitors with MarketBeat's FREE daily newsletter. Advanced Accelerator Application (NASDAQ:AAAP) Frequently Asked Questions How were Advanced Accelerator Application's earnings last quarter? Advanced Accelerator Application SA (NASDAQ:AAAP) announced its quarterly earnings results on Thursday, August, 31st. The company reported ($0.13) earnings per share for the quarter, missing analysts' consensus estimates of ($0.12) by $0.01. The company had revenue of $40.14 million for the quarter, compared to analysts' expectations of $36.74 million. View Advanced Accelerator Application's earnings history. Has Advanced Accelerator Application been receiving favorable news coverage? News articles about AAAP stock have been trending negative on Thursday, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Advanced Accelerator Application earned a news impact score of -2.8 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news about Advanced Accelerator Application. Who are some of Advanced Accelerator Application's key competitors? Some companies that are related to Advanced Accelerator Application include Aeolus Pharmaceuticals (AOLS), Affymax (AFFY), American Oriental Bioengineering (AOBI), Anthera Pharmaceuticals (ANTH), Aoxing Pharmaceutical (AOXG), Bohai Pharmaceuticals Group (BOPH), Epirus Biopharmaceuticals (EPRSQ), ERBA Diagnostics (ERBA), FutureWorld (FWDG), GlobeImmune (GBIM), Myrexis (MYRX), Pivotal Therapeutics (PVTTF), Poniard Pharmaceuticals (PARD), Skystar Bio-Pharmaceutical (SKBI) and Sunwin Stevia International (SUWN). View all competitors. What other stocks do shareholders of Advanced Accelerator Application own? Based on aggregate information from My MarketBeat watchlists, some companies that other Advanced Accelerator Application investors own include Comerica (CMA), Honda Motor (HMC), Albemarle (ALB), Editas Medicine (EDIT), Landec (LNDC), MGT Capital Investments (MGTI), NII (NIHD), Clinigen Group (CLIN), Directa Plus (DCTA) and First Hawaiian (FHB). Who are Advanced Accelerator Application's key executives? Advanced Accelerator Application's management team includes the following people: Susanne Schaffert, Chairman of the BoardStefano Buono, Chief Executive Officer (Age 52)Heinz Mausli, Chief Financial Officer (Age 52)Gerard Ber, Chief Operating Officer (Age 57)Claude A. Hariton Ph.D., Head of Clinical Development (Age 59)Maurizio Franco Mariani, Global Head of Pre-Clinical Research (Age 55)Frederic Collet, DirectorAugusto Lima, DirectorJessica Toepfer, DirectorKapil Dhingra, Independent Director (Age 58) When did Advanced Accelerator Application IPO? (AAAP) raised $76 million in an IPO on Thursday, February 5th 2015. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. Citigroup and Jefferies acted as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers. What is Advanced Accelerator Application's stock symbol? Advanced Accelerator Application trades on the NASDAQ under the ticker symbol "AAAP." What is Advanced Accelerator Application's stock price today? One share of AAAP stock can currently be purchased for approximately $81.63. What is Advanced Accelerator Application's official website? The official website for Advanced Accelerator Application is www.adacap.com. How can I contact Advanced Accelerator Application? Advanced Accelerator Application's mailing address is 20 Rue Diesel, Saint Genis Pouilly I0, 01630. The company can be reached via phone at 33-04-50-99-30-70 or via email at [email protected] This page was last updated on 8/6/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
